IDH1 and glioblastoma: The idea of detecting CTCs, ctDNA and exosomes that carry predictive markers for GBM, such as IDH1, MGMT and EGFRvIII, is interesting as it can represent a way of getting diagnostic and prognostic information in a non-invasive manner.